Xi Has 'Bowed To Reality,' Says China Analyst, Urges More Engagement Between Leaders To Resolve Trade Issues: 'No Substitute For Direct Negotiations With Trump'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
As U.S. President Donald Trump and Chinese President Xi Jinping break the ice with a phone call after months of silence, analysts weigh in on what's in store for the U.S.-China trade.
What Happened: The U.S. and China have been at odds over trade for a considerable period. The call signifies some advancement in establishing ground rules for a potential meeting. Jeremy Chan, Senior China Analyst at the Eurasia Group consultancy, stated that this communication suggests a level of respect from President Trump towards President Xi, reported The South China Morning Post.
Trending: Start investing with eToro's CopyTrader — .
However, analysts have noted that more than optimistic statements are required to resolve the deeply rooted trade differences between the two nations. Chan further noted that Xi typically consents to meetings with foreign leaders only after substantial groundwork has been laid through lower-level diplomatic efforts.
"Xi has bowed to reality, like so many other foreign leaders before him, that there is no substitute for direct negotiations with Trump," stated Chan, who is also a former U.S. diplomat.
On the other hand, ASPI's Wendy Cutler highlighted the complexity of the upcoming trade talks and the challenges.
"The likelihood of further misunderstandings, coupled with a fundamental lack of trust, will present enormous challenges for the negotiators as they try to hammer out a deal," cautioned Cutler.Why It Matters: This phone call comes in the wake of escalating trade tensions between the two countries. On Thursday, U.S. stocks dipped following reports of a phone call between Presidents Donald Trump and Xi Jinping, signaling a possible thaw in China trade tensions. The outreach was said to have come from the U.S. side, as per CNBC, citing Chinese state media.
Earlier in May, President Trump had expressed his willingness to travel to China to meet with President Xi Jinping, emphasizing the importance of the U.S.-China relationship.
In early May, the South China Morning Post reported that the U.S. and China are struggling to resume trade talks. China suggested using special envoys, but the U.S. prefers direct talks between Trump and Xi—a move China considers 'risky and uncertain.'
This latest phone call could be seen as a step towards that potential meeting, and a move towards resolving the trade disputes.
Baidu Inc (NASDAQ:BIDU) and Alibaba Group Holding Ltd – ADR (NYSE:BABA) climbed 1.13% and 0.43%, respectively, on Thursday. Meanwhile, JD.com Inc. (NASDAQ:JD) declined 0.72%
Read Next:
Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.
Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.
Image via Shutterstock
This article Xi Has 'Bowed To Reality,' Says China Analyst, Urges More Engagement Between Leaders To Resolve Trade Issues: 'No Substitute For Direct Negotiations With Trump' originally appeared on Benzinga.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Wall Street Says Supermicro Stock Could Gain 60% in a Year
Super Micro Computer (SMCI) has weathered significant volatility in recent times, with its stock experiencing a rollercoaster ride. After reaching significant highs, the stock experienced steep declines due to a range of concerns, including allegations of accounting irregularities and a delay in filing its financial reports with the SEC. Nonetheless, SMCI stock has made an impressive recovery recently, climbing 50% year-to-date. 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Dear Tesla Stock Fans, Mark Your Calendars for June 30 Nvidia Is Quickly Approaching a New Record High. Is It Too Late to Buy NVDA Stock? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Supermicro's stock came under heavy pressure following headlines that shook investor confidence. Allegations of accounting irregularities and a delay in filing annual reports sparked concerns about the possibility of delisting from the Nasdaq Exchange. The company eventually filed its financials, avoiding that outcome, but the damage to investor sentiment was already done. Adding to this were disappointing quarterly earnings. For its fiscal Q3 2025, Supermicro reported $4.6 billion in revenue, a 19% increase year-over-year but a 19% drop quarter-over-quarter. The results missed Wall Street's expectations, mainly due to customers holding back purchases amid uncertainty around new AI platform transitions, particularly Nvidia's (NVDA) move from Hopper to Blackwell GPU architecture. These delays contributed to the shortfall in expectations and added further pressure on the stock. These issues, however, now appear to be in the rearview mirror as those delays are beginning to turn into future growth opportunities. As customers resume spending, Supermicro appears poised to regain momentum. Furthermore, Supermicro recently announced a $20 billion partnership with Saudi Arabia-based DataVolt, which significantly boosted its stock. This deal strengthens the company's demand pipeline and will support future growth. Given these positive developments and continued investments in artificial intelligence (AI) infrastructure, SMCI stock is likely to trend higher. The highest price target for Supermicro stock is $70, courtesy of Loop Capital analyst Ananda Baruah. This target implies nearly 60% upside potential from here. Supermicro is well-positioned to benefit from secular tailwinds in the AI infrastructure market. The company specializes in building high-performance server and storage systems, many of which are now tailored specifically for AI workloads. This provides a significant runway for growth, as it strengthens the company's position to capitalize on AI demand. Thanks to the solid demand, over 70% of Supermicro's total revenue is now derived from AI GPU platforms, reflecting that the company could deliver significant growth as investments in AI continue to rise. Further, to meet the growing demand, Supermicro continues to expand its product portfolio. It has ramped up the production of its Data Center Building Block Solutions (DCBBS), which offer energy-efficient systems for next-generation computing. The company continues to roll out new products, including a range of air-cooled and liquid-cooled AI systems and racks. It has broadened its platform support to include AMD's newest AI accelerators. The expansion of SMCI's product portfolio is expected to help drive its market share higher. Supermicro is strengthening its leadership in the high-performance computing space with its technology to reduce environmental impact. The company's direct liquid cooling (DLC) technology helps lower energy costs, a critical factor as AI workloads become increasingly power-hungry. Furthermore, the rollout of its second-generation DLC-2 system will offer improved energy efficiency and thermal performance, which is expected to drive demand. Moreover, Supermicro's DCBBS reduces the time and complexity involved in building modern data centers. As the demand for scalable, plug-and-play infrastructure grows, DCBBS could become a significant growth driver for the company. The growing use of AI, which requires enhanced data center capabilities, will substantially increase demand for Supermicro's products. Supermicro's ability to design and deliver customized hardware solutions will help meet the specific needs of AI-driven workloads, strengthening its competitive positioning. Moreover, its focus on innovation, including energy-efficient green computing products and enhanced production of its DCBBS, positions it well to gain a higher market share. Analysts maintain a 'Moderate Buy' consensus rating on SMCI stock. However, given the strength of its product lineup and the booming demand in the AI and data center spaces, it wouldn't be surprising to see Supermicro's stock push toward the $70 mark in the near future. On the date of publication, Amit Singh did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
21 minutes ago
- Yahoo
Barabak: Newsom stood tall against Trump. Does that make him presidential timber?
Today we discuss presidential politics, window treatments and disasters of the natural and man-made variety. Time for Gavin Newsom to start measuring those White House drapes. Huh? You know, president of the United States. I'm thinking something Earth-friendly, like recycled hemp. Wait, what? Did you catch the nationally televised speech the governor recently gave? The one about "democracy at a crossroads." I did. It was a fine speech and the governor made some important points about President Trump's reckless commandeering of California's National Guard, his administration's indiscriminate immigration raids and the wholly unnecessary dispatch of Marines to Los Angeles. (From the halls of Montezuma, to the shores of Venice Beach.) Newsom was plenty justified in his anger and contempt. Trump, acting true to his flame-fanning fashion, turned what was a middling set of protests — nothing local law enforcement couldn't handle — into yet another assault on our sorely tested Constitution. Newsom's speech certainly "met the moment," to use one of his favorite phrases. I'll grant you that. Unlike a lot of extracurricular activities aimed at boosting his presidential prospects, Newsom was addressing a Trump-manufactured crisis unfolding right here at home. It was a moment that called for gubernatorial leadership. Just the kind of leadership despondent Democrats need. So it's been said. It's not much of a leap to see Newsom leading the anti-Trump opposition clear to the White House! Actually, that's a bigger leap than it takes to clear the Grand Canyon. Read more: Barabak: Putting the bully in bully pulpit, Trump escalates in L.A. rather than seeking calm Granted, Newsom's speech received a lot of raves from Democrats across the country. Many are desperate for someone in a position of power to give voice to their blood-boiling, cranium-exploding rage against Trump and his many excesses. Newsom did a good job channeling those emotions and articulating the dangers of an imprudent president run amok. But let's not go overboard. There is no lack of Democrats eager to take on Trump and become the face of the so-called resistance. There is no shortage of Democrats eyeing a 2028 bid for the White House. Those who run won't be schlepping all the political baggage that Newsom has to tote. Such as? Rampant homelessness. An exploding budget deficit. Vast income inequality. Plus, a lot of social policies that many Californians consider beneficent and broad-minded that, to put it mildly, others around the country consider much less so. Don't get me wrong. I love California with all my heart and soul. But we have a lot of deep-seated problems and cultural idiosyncrasies that Newsom's rivals — Democrat and Republican — would be only too happy to hang around his neck. So let's not get too caught up in the moment. The fundamentals of the 2028 presidential race haven't changed based on a single — albeit well-received — speech. It's still hard to see Democrats turning the party's fate over to yet another nominee spawned in the liberal stew of San Francisco politics and campaigning with kooky California as a home address. Stranger things have happened. True. That said, 2028 is a zillion political light years and countless news cycles away. First come the midterm elections in November 2026, giving voters their chance to weigh in on Trump and his actions. The verdict will go a long way toward shaping the dynamic in 2028. Well at least Newsom has brought his A-game to social media. His trolling of Trump is something to behold! Whatever. Read more: Lopez: My theory for why Trump's agents targeted Dodger Stadium and a bus stop outside Winchell's You're not impressed? I think it's best to leave the snark to professionals. I do, however, have some sympathy for the governor. It's not easy dealing with someone as spiteful and amoral as the nation's ax-grinder-in-chief. Consider, for instance, the disaster relief money that fire-devastated Southern California is counting on. Helping the region in its time of desperate need shouldn't be remotely political, or part of some red-vs.-blue-state feud. Historically, that sort of federal aid has never been. But this is Trump we're dealing with. To his credit, Newsom tried making nice in the days and weeks following the January firestorm. He ignored the president's provocations and held what was later described an an amicable session with Trump in the Oval Office. Their working relationship seemed to be a good one. Read more: Barabak: If Gavin Newsom wants to be president, he's got work to do — starting at home But few things last with the transactional Trump, save for his pettiness and self-absorption. Asked last week if his "recent dust-ups" with Newsom would impact the granting of wildfire relief, Trump said, "Yeah, maybe." He called Newsom incompetent, trotted out more gobbledygook about raking forests and then soliloquized on the nature of personal relationships. "When you don't like somebody, don't respect somebody, it's harder for that person to get money if you're on top," Trump said. Yeesh. Responding in a posting on X, Newsom correctly noted, "Sucking up to the President should not be a requirement for him to do the right thing for the American people." Hard to argue with that. Yet here we are. The nation's second-most populous city is occupied by National Guard and Marine troops. Thousands of people — displaced by disaster, their past lives gone up in smoke — are hostage to the whims of a peevish president who always puts his feelings first and cares nothing for the greater good. The midterm election can't come soon enough. Get the latest from Mark Z. BarabakFocusing on politics out West, from the Golden Gate to the U.S. me up. This story originally appeared in Los Angeles Times.
